Education
About Us
Working with TipRanks
Follow Us
Terns Pharmaceuticals (TERN)
NASDAQ:TERN
Terns Pharmaceuticals (TERN) Ownership Overview
0.92% Insiders
9.60% Mutual Funds
16.18% Other Institutional Investors
10.38% ETFs
62.92% Public Companies and
Individual Investors
The ownership structure of Terns Pharmaceuticals (TERN) stock is a mix of institutional, retail, and individual investors. Approximately 36.15% of the company’s stock is owned by Institutional Investors, 0.92% is owned by Insiders, and 62.92% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 06, 2026 | xxxxxxxxxxxxx | $44544 | |
Oct 02, 2025 | xxxxxxxxxxxxx | $7401 | |
Jul 03, 2025 | xxxxxxxxxxxxx | $3634 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $39200 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $205878 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $442703 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $4473653 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $19260861 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,834,319 | Institution | 4.55% | 182,495,542 | |
| 4,237,468 | Institution | 3.99% | 159,964,417 | |
| 3,075,314 | Institution | 2.89% | 116,093,104 | |
| 984,574 | Institution | 0.93% | 37,167,669 | |
| 957,477 | Institution | 0.90% | 36,144,757 | |
| 842,928 | Institution | 0.79% | 31,820,532 | |
| 831,267 | Institution | 0.78% | 31,380,329 | |
| 763,486 | Institution | 0.72% | 28,821,597 | |
| 686,287 | Institution | 0.65% | 25,907,334 | |
| 476,190 | Insider | 0.45% | 17,976,173 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,075,314 | Institution | 2.89% | 116,093,104 | |
| 984,574 | Institution | 0.93% | 37,167,669 | |
| 957,477 | Institution | 0.90% | 36,144,757 | |
| 842,928 | Institution | 0.79% | 31,820,532 | |
| 831,267 | Institution | 0.78% | 31,380,329 | |
| 686,287 | Institution | 0.65% | 25,907,334 | |
| 449,500 | Institution | 0.42% | 16,968,625 | |
| 407,770 | Institution | 0.38% | 15,393,318 | |
| 298,463 | Institution | 0.28% | 11,266,978 | |
| 292,365 | Institution | 0.27% | 11,036,779 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,185,157 | Institution | 3.00% | 128,680,343 | |
| 2,117,327 | Institution | 1.99% | 79,929,094 | |
| 927,850 | Institution | 0.87% | 37,485,140 | |
| 731,472 | Institution | 0.69% | 27,613,068 | |
| 650,100 | Institution | 0.61% | 24,541,275 | |
| 421,395 | Institution | 0.40% | 17,024,358 | |
| 414,232 | Institution | 0.39% | 15,637,258 | |
| 235,306 | Institution | 0.22% | 8,882,802 | |
| 227,612 | Institution | 0.21% | 8,592,353 | |
| 207,480 | Institution | 0.20% | 7,832,370 |
FAQ
Who Owns Terns Pharmaceuticals (TERN)?
According to the latest TipRanks data, approximately 16.18% of the company's stock is held by institutional investors, 0.92% is held by insiders, and 62.92% is held by retail investors.
What percentage of Terns Pharmaceuticals (TERN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 16.18% of Terns Pharmaceuticals (TERN) stock is held by institutional investors.
What percentage of Terns Pharmaceuticals (TERN) stock is held by retail investors?
According to the latest TipRanks data, approximately 62.92% of Terns Pharmaceuticals (TERN) stock is held by retail investors.
Who owns the most shares of Terns Pharmaceuticals (TERN)?
Vanguard owns the most shares of Terns Pharmaceuticals (TERN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.